Cancer Vaccine by Fusions of Dendritic and Cancer Cells
Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary immune responses. Therefore, their use for the active immunotherapy against cancers has been studied with considerable interest. The fusion of DCs with whole tumor cells repr...
Saved in:
Main Authors: | Shigeo Koido, Eiichi Hara, Sadamu Homma, Yoshihisa Namiki, Toshifumi Ohkusa, Jianlin Gong, Hisao Tajiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2009/657369 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
by: Shigeo Koido, et al.
Published: (2010-01-01) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
Effect of dendritic cell vaccine on blood redox status in patients with cervical cancer
by: A. P. Menshenina, et al.
Published: (2023-03-01) -
Application of Autofluorescence Endoscopy for Colorectal Cancer Screening: Rationale and an Update
by: Hiroyuki Aihara, et al.
Published: (2012-01-01) -
Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity
by: Jurjen Tel, et al.
Published: (2016-01-01)